Endogenex

Endogenex is developing a medical device system that uses controlled pulsed electric fields delivered to the small intestine to reset metabolic signaling in people with type 2 diabetes, with the goal of helping patients regain control of blood glucose levels. The company, founded in partnership with Mayo Clinic, is currently evaluating the Endogenex system through clinical trials and has not yet received approval for commercial sale.